PP
MLAB icon

PDT Partners’s Mesa Laboratories MLAB Stock Holding History

PDT Partners’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,273
Closed -$295K – 783
2024
Q3 		$295K Buy
+2,273
New +$267K 0.03% 606
2024
Q2 		– Sell
-4,838
Closed -$531K – 714
2024
Q1 		$531K Hold
4,838
– – 0.05% 443
2023
Q4 		$507K Buy
+4,838
New +$471K 0.06% 405
2023
Q3 		– Sell
-6,671
Closed -$857K – 645
2023
Q2 		$857K Sell
6,671
-1,696
-20% -$258K 0.12% 280
2023
Q1 		$1.46M Buy
+8,367
New +$1.5M 0.2% 183
2021
Q2 		– Sell
-900
Closed -$219K – 906
2021
Q1 		$219K Buy
900
+200
+29% +$55K 0.02% 690
2020
Q4 		$201K Buy
+700
New +$193K 0.01% 610
2020
Q1 		– Sell
-932
Closed -$232K – 782
2019
Q4 		$232K Buy
+932
New +$218K 0.01% 611
2014
Q3 		– Sell
-2,455
Closed -$206K – 1473
2014
Q2 		$206K Buy
+2,455
New +$203K 0.01% 1311

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PDT Partners's MLAB Position: Q4 2024 in Review

PDT Partners sold out of Mesa Laboratories (MLAB) in Q4 2024, closing a stake of 2,273 shares — an estimated $295K sold.

PDT Partners first reported a position in MLAB in Q2 2014 and held it in 9 quarters. The position peaked at $1.46M in Q1 2023. 156 funds tracked by Wall St. Rank hold MLAB as of Q4 2024.

  • PDT Partners reported no remaining Mesa Laboratories position as of Q4 2024 after selling out during the quarter.
  • PDT Partners sold 2,273 Mesa Laboratories shares in Q4 2024, an estimated $295K.
  • PDT Partners first reported a position in Mesa Laboratories in Q2 2014 and held it in 9 quarters.
  • PDT Partners's Mesa Laboratories position peaked at $1.46M in Q1 2023.
  • 156 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2024.

Based on PDT Partners's 13F filing for Q4 2024, filed 14 Feb 2025.